A detailed history of Palisade Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Palisade Asset Management, LLC holds 20,035 shares of BMY stock, worth $1.13 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
20,035
Previous 18,109 10.64%
Holding current value
$1.13 Million
Previous $752,000 37.77%
% of portfolio
0.1%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $76,385 - $99,670
1,926 Added 10.64%
20,035 $1.04 Million
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $58,523 - $77,047
-1,454 Reduced 7.43%
18,109 $752,000
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $10,795 - $12,240
225 Added 1.16%
19,563 $1.06 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $113,831 - $135,831
-2,348 Reduced 10.83%
19,338 $992,000
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $43,996 - $49,194
760 Added 3.63%
21,686 $1.26 Million
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $9,237 - $10,257
145 Added 0.7%
20,926 $1.34 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $12,090 - $13,713
-184 Reduced 0.88%
20,781 $1.44 Million
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $1,848 - $2,189
27 Added 0.13%
20,965 $1.51 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $1 - $845
11 Added 0.05%
20,938 $1.49 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $10,021 - $11,037
-138 Reduced 0.66%
20,927 $1.61 Million
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $273,586 - $328,054
4,450 Added 26.78%
21,065 $1.54 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $74,009 - $86,277
-1,380 Reduced 7.67%
16,615 $1.04 Million
Q3 2021

Oct 25, 2021

BUY
$59.17 - $69.31 $48,756 - $57,111
824 Added 4.8%
17,995 $1.07 Million
Q2 2021

Jul 22, 2021

BUY
$61.91 - $67.42 $27,054 - $29,462
437 Added 2.61%
17,171 $1.15 Million
Q1 2021

May 04, 2021

BUY
$59.34 - $66.74 $55,482 - $62,401
935 Added 5.92%
16,734 $1.06 Million
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $12,921 - $14,319
225 Added 1.44%
15,799 $953,000
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $8,606 - $10,062
-157 Reduced 1.0%
15,574 $916,000
Q1 2020

Apr 24, 2020

BUY
$46.4 - $67.43 $23,664 - $34,389
510 Added 3.35%
15,731 $877,000
Q4 2019

Jan 16, 2020

BUY
$49.21 - $64.19 $79,769 - $104,051
1,621 Added 11.92%
15,221 $977,000
Q3 2019

Oct 16, 2019

BUY
$42.77 - $50.71 $29,939 - $35,497
700 Added 5.43%
13,600 $690,000
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $21,417 - $23,683
480 Added 3.86%
12,900 $585,000
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $65,423 - $78,010
1,450 Added 13.22%
12,420 $593,000
Q4 2018

Jan 16, 2019

BUY
$48.76 - $63.23 $15,847 - $20,549
325 Added 3.05%
10,970 $570,000
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $42,950 - $53,533
850 Added 8.68%
10,645 $589,000
Q1 2018

Apr 25, 2018

SELL
$59.92 - $68.98 $5,992 - $6,898
-100 Reduced 1.01%
9,795 $620,000
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $48,326 - $55,772
875 Added 9.7%
9,895 $631,000
Q3 2017

Oct 26, 2017

BUY
$55.23 - $63.74 $498,174 - $574,934
9,020
9,020 $575,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Palisade Asset Management, LLC Portfolio

Follow Palisade Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Asset Management, LLC with notifications on news.